About KEVYS
KEVYS is a company based in Hyderabad (India) founded in 2012. It operates as a B2B. The company has 9 employees. KEVYS offers products and services including Acyclovir Powder, Carvedilol Powder, Citalopram Hydrobromide Powder, and Escitalopram Oxalate Powder.
- Headquarter Hyderabad, India
- Employees 9
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website kevyslabs.com
- Employee Count9
Associated legal entities of KEVYS
KEVYS is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kevy's Organics Private Limited CIN U24302TG2019PTC129446 | Active | 03 Jan 2019 | Hyderabad, Telangana | ₹19.9 Cr | 17 | 2 | View details |
| Kevy's Generics Private Limited CIN U24233TG2008PTC059172 | Active | 14 May 2008 | Hyderabad, Telangana | ₹26.7 Cr | – | 4 | View details |
Products & Services of KEVYS
KEVYS offers a comprehensive portfolio of products and services, including Acyclovir Powder, Carvedilol Powder, Citalopram Hydrobromide Powder, and Escitalopram Oxalate Powder.
Antiviral compound used in medication production
Beta-blocker for cardiovascular treatments
Antidepressant ingredient for mental health applications
Selective serotonin reuptake inhibitor for anxiety disorders
Board of directors of KEVYS
The boards of the 2 registered companies of KEVYS currently have 5 directors; the longest-serving is Veeraiah Kavuri, appointed in 2013. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Veeraiah Kavuri DIN 06496415 | Managing Director | 12 Feb 2013 | 13 yrs 7 mo | Kevy's Generics Private Limited, Kevy's Organics Private Limited |
| Srinivasa Reddy Annapu Reddy DIN 06496412 | Director | 12 Feb 2013 | 13 yrs 7 mo | Kevy's Generics Private Limited |
| Nadapana Rao Srinivasa DIN 06609180 | Additional Director | 18 Oct 2013 | 12 yrs 11 mo | Kevy's Generics Private Limited |
| Venkata Rama Rao Edupuganti DIN 06496442 | Director | 03 Mar 2014 | 12 yrs 7 mo | Kevy's Generics Private Limited |
| Priyanka Kavuri DIN 06496409 | Director | 03 Jan 2019 | 7 yrs 9 mo | Kevy's Organics Private Limited |
Financials of KEVYS
Figures of Kevy's Generics Private Limited, the primary company behind KEVYS, for FY 2024. Revenue was ₹26.72 Cr (+9% year on year). Net profit was ₹24.6 Lakh (1% margin). EBITDA was ₹2.55 Cr (10% margin). Revenue has grown at a compounded annual rate of -6% over three years and +4% over five years.
- ₹26.72 CrRevenue · FY 2024 · +9% YoY
- ₹24.6 LakhNet profit · 1% margin
- ₹2.55 CrEBITDA · 10% margin
- ₹1.10 CrPaid-up capital
- -6%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kevy's Generics Private Limited are on its company page.
Detailed financial statements for KEVYS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to KEVYS
10 companies that operate in the same segment as KEVYS (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about KEVYS
KEVYS was founded in 2012.
KEVYS is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
KEVYS has 9 employees.
Kevys Labs, based in Hyderabad, India, develops and manufactures high-quality Active Pharmaceutical Ingredients (APIs) and drug intermediates. Established in 2012, they operate ISO and GMP certified facilities in Andhra Pradesh and Telangana. The company focuses on supplying these products to domestic and international markets through manufacturing and export activities, serving pharmaceutical industries with competitive pricing and quality assurance.
KEVYS offers Acyclovir Powder, Carvedilol Powder, Citalopram Hydrobromide Powder, and Escitalopram Oxalate Powder.
KEVYS is associated with 2 legal entities: Kevy's Generics Private Limited, Kevy's Organics Private Limited.
The legal entities of KEVYS currently have 5 directors, including Nadapana Rao Srinivasa, Veeraiah Kavuri, Venkata Rama Rao Edupuganti and others.